Table 1.
Demographic, clinical, and biochemical characteristics of study participants.
| Control group (n=25) | Patients with postoperative hypothyroidism (PO, n=16) | Patients with AIT-induced hypothyroidism (AIT with hypothyroidism, n=65) | Patients with AIT and elevated anti-Tg and anti-TPO antibodies (AIT, n=72) | |
|---|---|---|---|---|
| Age (years) | 46.08±14.58 | 47.30±12.27 | 46.72±15.49 | 45.02±13.65 |
| fT4 (pmol/L) | 8.91±0.97 | 3.44±0.31 | 4.13±0.52 | 8.51±0.82 |
| TSH (mIU/mL) | 2.67±0.52 | 8.61±0.84 | 7.09±0.50 | 2.38±0.62 |
| anti-TPO (IU/mL) | 34.04±3.70 | 36.13±2.78 | 380.62±73.42 | 330.36±50.23 |
| anti-TG (IU/mL) | 15.32±1.97 | 15.50±1.90 | 32.97±4.27 | 36.38±7.70 |
| Current dose of L-thyroxine (μg/day) | None | 110.95±5.25 | 88.46±1.55 | None |
| 25-OH Vitamin D | 39.2±6.58 | 20.69±3.09 (p<0.001) | 19.08±3.144 (p<0.001) | 21.48±2.83 (p<0.001) |
Data are presented as mean ± standard deviation. * p-value between control and study groups.